Vasodilates - PowerPoint PPT Presentation

About This Presentation
Title:

Vasodilates

Description:

Nobel Prize in Medicine awarded in 1998 to 3 physicians 'for their discoveries ... Loss and Coronary Heart Disease, Archives of Otolaryngology, 82:236 (1965) ... – PowerPoint PPT presentation

Number of Views:89
Avg rating:3.0/5.0
Slides: 30
Provided by: michae1253
Learn more at: https://s2.smu.edu
Category:

less

Transcript and Presenter's Notes

Title: Vasodilates


1
Vasodilates
  • Michael Evans
  • April 17, 2008

2
Overview
  • History
  • Purposes of vasodilates
  • Mechanisms of different vasodilates
  • Commonly used vasodilators, for therapeutic
    effects

3
History
  • Nobel Prize in Medicine awarded in 1998 to 3
    physicians "for their discoveries concerning
    nitric oxide as a signalling molecule in the
    cardiovascular system"

4
History, continued
  • Synthesized in 1846, nitroglycerin was first used
    to treat anginal attacks in 1879. It was granted
    FDA approval in 1938.
  • Explosion of vasodilator therapy research in the
    1970s
  • When ACE inhibitor therapy first appeared
  • More research in the 80s and 90s to determine
    long-term effects, as usage to garner acute
    effects has already been proven to work
  • One can build up a tolerance to vasodilators, so
    dosages must be increased or there must be a
    nitrate-free interval
  • Since all methods work via different mechanisms
    and pathways, theres no such thing as simple
    vasodilator research
  • Nitroprusside
  • Nitrates
  • ACE inhibitors
  • Angiotensin II antagonists
  • Calcium Channel Blockers
  • Nitroprusside, nitrates, hydralazine are direct
    vasodilators
  • AII antagonists and ACE inhibitors also have
    indirect components

5
History, continued
  • VHeFTI trial (1986) first to prove increased
    survival rates with vasodilator treatment for
    patients with Class II and Class III heart
    failure
  • Known as a mortality study
  • Vasodilation affects the relationship between
    mean arterial pressure, cardiac output, and total
    peripheral resistance
  • Your heart pumps against a constant pressure, and
    you can damage your heart if TPR is too high
    hypertension/high blood pressure
  • Although blood viscosity hematocrit-determined
    and length of blood vessels contribute to TPR,
    the most important variable is vessel diameter,
    which relates directly to surrounding smooth
    muscle

6
Blood Vessels
7
Homeostatic Mechanisms
  • Baroreceptors
  • Constant monitor
  • Neck/chest most important
  • When there is a change in blood pressure,
    physiologic mechanisms triggered

8
Extreme Dilation of Blood Vessels
  • Alcohol
  • Some allergic reactions
  • Some antidepressants
  • amitriptyline
  • Antihypertensive drugs that dilate blood vessels
    (such as calcium channel blockers,
    angiotensin-converting enzyme inhibitors, and
    angiotensin II receptor blockers)
  • Nitrates
  • Bacterial infections
  • Heat
  • Nerve damage (such as that due to diabetes,
    amyloidosis, or spinal cord injuries)
  • In this case, the homeostatic controls lose their
    function

9
Endogenous rising from within Vasodilators
  • Depolarization, which yields decreased
    intracellular Ca2
  • Nitric Oxide Pathway, stimulating cGMP ? MLCK
    pathway, which ends up decreasing intracellular
    Ca2
  • Beta-2 Andrenergic Receptor antagonists,
    histamine, prostaglandins, and prostacyclin
  • VIP
  • Adenosine
  • ATP and ADP
  • L-Arginine
  • Bradykinin
  • Muscle use

10
Endogenous Vasodilators Hyperpolarization
  • Endothelium-derived hyperpolarizing factor EDHF
  • Depolarization, which opens Voltage-gated K
    channels
  • Increase in Interstitial K
  • All of the above hyperpolarize the membrane,
    closing voltage-dependent calcium channels,
    decreasing intracellular Ca2
  • Effectively the same as Ca2 channel blockers

11
Hyperpolarization Intracellular Ca2
  • As you know, muscle contraction occurs when
    VDCCs open, allowing Ca2 to flow into the cell
  • A vasodilator needs to inhibit smooth muscle
    contraction around blood vessels
  • Thus, membrane hyperpolarization to prevent these
    voltage gated channels from opening works to
    achieve this goal

12
Endogenous Vasodilators Nitric Oxide
  • Nitric Oxide acts on the lyase enzyme Guanylate
    Cyclase GC
  • This enzyme catalyzes the conversion of GTP to
    3,5-cyclic guanosine monophosphate better
    known as cGMP and pyrophosphate
  • Because there are multiple GCs, one
    membrane-bound and one soluble, it is important
    to clarify that the NO-receptor is the soluble GC
    receptor
  • cGMP then regulates cellular proteins, yielding
    vasodilation

GTP
cGMP
13
cGMP Mechanisms of Action
  • Second messenger
  • Activates intracellular protein kinases pks
  • cGMP relaxes smooth muscles

14
Renin-Angiotensin-Aldosterone Systemas it
pertains to vasodilation
  • RAA system is blocked with ACEI
  • Angiotensin II is turned off
  • This allows indirect acute vasodilatation through
    withdrawal of angiotensin II and the accumulation
    of bradykinin (as ACEI are kininases) which also
    contributes to the vasodilator effect

15
Bradykinin
  • 9-AA Peptide Chain
  • Released from Venules
  • Endothelium-dependent vasodilator
  • Broken down by Angiotensin-converting enzyme (ACE)

16
Exogenous from outside the body Vasodilators
  • Quiet, dark
  • Adenosine antagonists
  • Alpha-blockers
  • Amyl nitrite - popper
  • Alcohol ethanol
  • Histamine-inducers
  • Nitric Oxide Inducers
  • THC

17
Environmental Factors
  • Noise
  • Excessive noise, annoying noise
  • Raise blood pressure, cause hypertension
  • Increased stress shown by study
  • 5-10 point rise in blood pressure,
    vasoconstriction
  • Light
  • Clinically measurable stress found from
    overexposure
  • People that work in extremely bright environments
    are more prone to hypertension

18
Calcium Channel Blockers
  • Calcium channel blockers reduce heart rate
  • Dilate the blood vessels of the heart
  • Decrease oxygen demand
  • Increase oxygen supply
  • Net drop in BP

19
Alpha-Blockers
  • Alpha-adrenergic blocking agents
  • In both arteries and smooth muscles
  • The blocked adrenergic receptors are G
    protein-coupled receptors
  • Catecholamines adrenaline/noradrenalineepi/nore
    pi
  • If catecholamines bind, increased HR,
    vasoconstriction
  • However, if B-adrenergic receptors are bound by
    epi or norepi, vasodilation occurs

20
More on Alpha Adrenergic Receptors
21
Nitric Oxide NO Inducers
  • Glyceryl trinitrate (Nitroglycerin)
  • Prodrug, must be denitrated to produce active NO
  • Once active, these nitrates are called
    nitrovasodilators

22
Mechanisms for Denitration
  • Nitroglycerin can be denitrated in many ways
  • There are many hypotheses as to the mechanism of
    bioactivation
  • Nitrates react with sulfhydryl groups
  • Enzymatic breakdown
  • Glutathione S-transferase, Cytochrome P450,
    Xanthine oxidoreductase
  • Catalyzed denitration by mitochondrial aldehyde
    dehydrogenase
  • Ultimately, GTN is broken down into 1,2-glyceryl
    dinitrate Free NO

23
Other Nitric Oxide NO Inducers
  • Isosorbide mononitrate Isosorbide dinitrate
  • Preventatives of angina, reduced heart workload
  • Pentaerythritol Tetranitrate (PETN)
  • Lentonitrat drug commonly used, pure PETN
  • So reactiveone of the strongest high explosives
    known
  • Sodium nitroprusside
  • Salt that is a source of NO, often administered
    via IV
  • For patients with extreme hypertension
  • PDE5 inhibitors these agents indirectly increase
    the effects of nitric oxide
  • Sildenafil (Viagra)
  • Tadalafil
  • Vardenafil

24
Now what? Free NO
  • NO is a potent activator of guanylyl cyclase (GC)
    by heme-dependent mechanisms
  • Activation results in cGMP formation from
    guanosine triphosphate (GTP)
  • Thus, NO increases the level of cGMP within the
    cell.

25
Nitroglycerin
  • GENERIC NAME nitroglycerin
  • BRAND NAME Nitro-Bid Nitro-Dur Nitrostat
    Transderm-Nitro Minitran Deponit Nitrol
  • USES frequently used to lower blood pressure
    when treating angina pectoris, and also used
    during anginal attacks both as a prevention
    method, and as an acute treatment
  • Extended release tablets, translingual spray, and
    transdermal patches
  • Literature recommends not to stack with other
    high blood pressure medications, because of
    additive effects

26
ACE inhibitors
  • Class of Drugs ACE (angiotensin converting
    enzyme) inhibitors
  • Generic (Brand Name)
  • captopril (Capoten)
  • benazepril (Lotensin)
  • enalapril (Vasotec)
  • lisinopril (Prinivil, Zestril)
  • fosinopril (Monopril)
  • ramipril (Altace)
  • perindopril (Aceon)
  • quinapril (Accupril)
  • moexipril (Univasc)
  • trandolapril (Mavik)
  • USES
  • Hypertension treatment
  • Heart failure

27
Viagra (sildenafil citrate)
  • More than 65 of men with high blood pressure
    also have ED.
  • PDE5 Inhibitor
  • Side Effects
  • Priaprism
  • Sudden blindness

28
OTC Vasodilates
  • Preworkout supplements
  • Taken 30 minutes before exercise
  • Stimulate L-Arginine pathway, along with NOS

29
Sources
  • http//nobelprize.org/nobel_prizes/medicine/laurea
    tes/1998/index.html
  • http//en.wikipedia.org/wiki/Nitric_oxide
  • http//www.medicinenet.com/nitroglycerin/article.h
    tm
  • http//www.medicinenet.com/ace_inhibitors/article.
    htm
  • http//www.seloken.com/3430_9816.aspx?l1l2mid
  • S. Rosen and P. Olin, Hearing Loss and Coronary
    Heart Disease, Archives of Otolaryngology, 82236
    (1965)
  • http//en.wikipedia.org/wiki/Environmental_noisec
    ite_note-7
  • http//en.wikipedia.org/wiki/Adrenergic_receptorA
    lpha_.CE.B1_receptors
  • http//health.nytimes.com/health/guides/disease/co
    ronary-heart-disease/other-medications.html
  • http//www.merck.com/mmhe/print/sec03/ch023/ch023a
    .html
  • http//en.wikipedia.org/wiki/Bradykinin
  • http//content.answers.com/main/content/wp/en-comm
    ons/thumb/4/47/220px-Nitroglycerin-2D-skeletal.png
  • http//en.wikipedia.org/wiki/Amitriptyline
  • http//wwwchem.csustan.edu/chem4400/SJBR/Image1.gi
    f
  • http//fig.cox.miami.edu/cmallery/150/memb/fig11x
    12.jpg
  • http//www.usm.maine.edu/newton/Chy251_253/Lectur
    es/BiopolymersIII/BradykininPrimary.gif
  • http//www.mc.uky.edu/pharmacology/images/ped_fin2
    .gif
  • http//en.wikipedia.org/wiki/PDE5_inhibitor
Write a Comment
User Comments (0)
About PowerShow.com